The overarching aim of MentBest is to improve care for patients with depression and to prevent suicidal behaviour in Europe by i) transferring the community-based 4-level intervention concept of the European Alliance Against Depression (EAAD) to new regions and countries in Europe and ii) promoting the uptake of the iFightDepression®-tool, an internet-based self-management tool for patients with depression. Implementation countries (Bulgaria, Estonia, Greece, Italy and Poland) are those countries where EAAD’s 4-level intervention concept has not yet been implemented. In these countries, model regions have been selected in which the 4-level intervention will be implemented and later transferred to other regions. Transfer countries (Hungary, Ireland and Spain) are those countries in which the 4-level intervention concept has already been implemented. These countries will focus on promoting and expanding these interventions to new regions. Both implementation and transfer countries will furthermore promote and coordinate the nationwide implementation of the iFightDepression®-tool and awareness website. MentBest will contribute to reduce the huge diagnostic and therapeutic deficits concerning depression and to prevent suicidal behaviour in Europe, which is particularly timely considering the exacerbation of mental health problems associated with the impacts of Covid-19. Reducing stigma, improving health literacy and help-seeking behaviour are further objectives of MentBest. MentBest will start a long-term process of dissemination of both the 4-level intervention and the iFightDepression®-tool beyond the funding period. Experiences from EAAD member countries have demonstrated that other regions will be encouraged to adopt their own regional 4-level interventions as soon as culturally sensitive materials and support (e.g. by national coordination centre) are available. An explicit goal of Mentbest is to thus ensure long-term sustainability via this self-promoting process.


This proposal answer the ERN call 2016 and FPA, for the ERN on Rare Multisystemic Vascular Diseases.
The ERN is coordinated by the ERN Network Coordinator, Pr. Guillaume JONDEAU - AP-HP, Hôpital Bichat-Claude Bernard, CRMR Marfan Diseases and related disorders (Centre de Référence Maladies Rares Syndrome de Marfan et apparentés).
Our ERN project aims to facilitate and improve diagnosis, treatment and care for ALL patients suffering from Rare Multisystemic Vascular Diseases, thus enhancing access to care, and improving quantity and quality of life of these patients.
Networking, sharing and spreading our expertise, promoting best practices, guidelines and clinical outcomes, patient-empowerment, improving knowledge through clinical and basic research are among our objectives.
The European Reference Network project on Rare Multisystemic Vascular Diseases gathers European highly specialized multidisciplinary Healthcare Providers (HCPs) in this thematic area of expertise. The Network includes specific Rare Diseases Working Groups: Heritable Thoracic Aortic Diseases, HHT, Medium Sized Arteries (vascular Ehlers Danlos), Pediatric and Primary Lymphedemas, Vascular Anomalies (VASCA). The specific Patients-WG enables Patient representatives to work on common issues and to be involved in all activities. In addition, several Thematic Working Groups are established to better tackle transversal issues on: eHealth, Training & Education, Patient Registry, Ethics, and Communication.
HCPs have developed extensive European collaborations through their specific Rare Diseases’ networks. They join this ERN Project proposal to foster and reinforce European cooperation in Rare Multisystemic Vascular Diseases, following a common and multidisciplinary approach to patient care, in order to overcome the challenges of rarity. They are committed to improve diagnosis, treatment, and care for patients by using all opportunities and activities, which can be offered by the ERN Project.


The aim of the Schools for Health in Europe (SHE) network is to improve the health of children and young people in Europe, including reducing health inequalities, through a specific setting focus on schools. The network supports its members to further develop and sustain school health promotion by providing a European platform for school health promotion.For 2015-2017 4 specific objectives are formulated. By the end of 2017:• the functioning of national and regional health promoting school networks and the implementation of health promoting schools has been supported by sharing good practices, expertise and skills;• the professional development of SHE network members and other stakeholders has been supported by the delivery of the SHE support programme;• the visibility and access to evidence based information on school health promotion has increased by the delivery of publications and presentations;• the dissemination of school health promotion research findings and innovative research consortia has been promoted.Methods to achieve these objectives are: organising annual meetings and capacity building workshops. Maintaining SHE website, helpdesk, share information through newsletters and social media and by encouraging regional and cross-border cooperation. Developing online school twinning tool and the SHE online school manual. Developing an e-learning tool, organising a summer school, support publications and consultancy visits. Making SHE leaflets, factsheets, an online glossary and by representing the network at international conferences.The health of children and young people are and will be a key priority for the European Commission. The activities in the network relate directly to the first overall objective of the third programme of community action in the field of health (2014-2020) and thematic priorities 1.1 till 1.4 are high priority issues in school programmes and settings. The SHE network encourages a whole school approach to these priorities.


The TB Europe Coalition (TBEC) is an advocacy network that brings together civil society representatives (individuals and organisations) from across the WHO European Region; in order to strengthen the role of civil society within the regional response to tuberculosis (TB), and to increase the political and financial commitment required to effectively control the epidemic in region. TBEC was formed by a group of TB advocates in 2009. They identified a need to capacitate and bring together civil society in order to address two major concerns: high-rates of drug resistance, coupled with low awareness among general populations and policy-makers about this problem. This was especially due to a scarcity of civil society stakeholders working on TB in the region, despite their important role within an effective response, with few capable of advocating for TB at national or regional level. TBEC addresses this by providing a coordinating body that brings together civil society stakeholders across the region, disseminates high-quality information and resources, promotes collaboration and best practice, and aims to build the advocacy capacity of civil society stakeholders working to control TB.


Within most European populations, smoking prevalence rates differ substantially according to people’s educational level, occupational class and income level. In the European countries, smoking inequalities are generally largest, and smoking is the largest single contributor to socio-economic inequalities in mortality. Significant inequalities in smoking are now emerging in all European countries, especially in the youngest generations. Tobacco products and secondhand smoke (SHS) kill, as documented in over 20 reports (eg: IARC, US Surgeon General). Exposure to SHS kills at least 79 000 people in the EU each year, incl. deaths from lung cancer, coronary heart disease, stroke and chronic non-neoplastic respiratory disease; plus deaths in childhood caused by SHS, deaths in adults from other conditions known to be caused by active smoking and the significant, serious morbidity, both acute and chronic, caused by SHS. Special Eurobarometer 385/2012 indicates that almost one third of European citizens currently smoke either cigarettes, cigars or a pipe. As smoking is responsible for half the difference in deaths across socio-economic groups, tobacco control has a major role to play in reducing health and social inequalities.ENSP plays a major role in Europe to prevent the tobacco industry from biaising and slowing down the tobacco control process. Indeed, ENSP was created for a tighter collaboration within the tobacco control community and for a stronger and united civil society action against tobacco. Key objectives during 2015-2017:- The support to the Directive 2014/40/EU and FCTC implementation- The facilitation of the creation and the operation of national alliances for tobacco control in Europe.- The stimulation of and the participation in European projects - The facilitation of networking in Europe- The collection and distribution of informationEuropean Network for Smoking and Tobacco Prevention 2015-2017: connecting, sharing, advocating to save lives!
